| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aconite Poisoning over 5 Years
|
Chen, Sammy Pak Lam
|
|
2012
|
|
7 |
p. 575-587
|
artikel
|
| 2 |
Acute Pancreatitis in Patients with Type 2 Diabetes Mellitus Treated with Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Nested Case-Control Study
|
Chou, Hsin-Chun
|
|
2014
|
|
7 |
p. 521-528
|
artikel
|
| 3 |
Adherence to Biochemical Monitoring Recommendations in Patients Starting with Renin Angiotensin System Inhibitors
|
Bootsma, Janet E. M.
|
|
2011
|
|
7 |
p. 605-614
|
artikel
|
| 4 |
Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals
|
Parameswaran Nair, Nibu
|
|
2017
|
|
7 |
p. 597-606
|
artikel
|
| 5 |
Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia
|
Bezabhe, Woldesellassie M.
|
|
|
|
7 |
p. 629-639
|
artikel
|
| 6 |
Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia
|
Bezabhe, Woldesellassie M.
|
|
2015
|
|
7 |
p. 629-639
|
artikel
|
| 7 |
A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World Data
|
Gray, Christen M.
|
|
|
|
7 |
p. 623-633
|
artikel
|
| 8 |
A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs
|
Sarpatwari, Ameet
|
|
|
|
7 |
p. 743-751
|
artikel
|
| 9 |
Analysis of Event Logs from Syringe Pumps
|
Kastrup, Marc
|
|
2012
|
|
7 |
p. 563-574
|
artikel
|
| 10 |
A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study
|
Montastruc, Jean-Louis
|
|
|
|
7 |
p. 657-660
|
artikel
|
| 11 |
An Observational Study of Cholecystectomy in Patients Receiving Tegaserod
|
Brinker, Allen
|
|
2007
|
|
7 |
p. 581-588
|
artikel
|
| 12 |
An Update on the International Society of Pharmacovigilance China Chapter
|
Wen, Yalu
|
|
|
|
7 |
p. 699-702
|
artikel
|
| 13 |
A Potential Event-Competition Bias in Safety Signal Detection: Results from a Spontaneous Reporting Research Database in France
|
Salvo, Francesco
|
|
2013
|
|
7 |
p. 565-572
|
artikel
|
| 14 |
Application of Information Retrieval Approaches to Case Classification in the Vaccine Adverse Event Reporting System
|
Botsis, Taxiarchis
|
|
2013
|
|
7 |
p. 573-582
|
artikel
|
| 15 |
A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia
|
Adenuga, Babafunso Aderemi
|
|
2019
|
|
7 |
p. 915-917
|
artikel
|
| 16 |
Are the Safety Profiles of Antipsychotic Drugs Used in Dementia the Same? An Updated Review of Observational Studies
|
Trifiró, Gianluca
|
|
2014
|
|
7 |
p. 501-520
|
artikel
|
| 17 |
A Signal Detection Method to Detect Adverse Drug Reactions Using a Parametric Time-to-Event Model in Simulated Cohort Data
|
Cornelius, Victoria R.
|
|
2012
|
|
7 |
p. 599-610
|
artikel
|
| 18 |
Association between Leukotriene-Modifying Agents and Suicide
|
Schumock, Glen T.
|
|
2011
|
|
7 |
p. 533-544
|
artikel
|
| 19 |
Association Between Use of Multiple Psychoactive Medicines and Hospitalization for Falls: Retrospective Analysis of a Large Healthcare Claim Database
|
Pratt, Nicole L.
|
|
2014
|
|
7 |
p. 529-535
|
artikel
|
| 20 |
Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis
|
Takeuchi, Yoshinori
|
|
2015
|
|
7 |
p. 641-650
|
artikel
|
| 21 |
Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.”
|
Gamble, John-Michael
|
|
|
|
7 |
p. 813-814
|
artikel
|
| 22 |
Bayesian Confidence Propagation Neural Network
|
Bate, Andrew
|
|
2007
|
|
7 |
p. 623-625
|
artikel
|
| 23 |
Behavioural Effects of the New Anticonvulsants
|
Besag, Frank M. C.
|
|
|
|
7 |
p. 513-536
|
artikel
|
| 24 |
Benefit-Risk Assessment of Ciclosporin Withdrawal in Renal Transplant Recipients
|
Thervet, Eric
|
|
|
|
7 |
p. 457-476
|
artikel
|
| 25 |
Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases
|
Kostapanos, Michael S.
|
|
2014
|
|
7 |
p. 481-500
|
artikel
|
| 26 |
Benefit-Risk Assessment of Telithromycin in the Treatment of Community-Acquired Pneumonia
|
Brown, Steven D.
|
|
2008
|
|
7 |
p. 561-575
|
artikel
|
| 27 |
Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources Database
|
Plueschke, Kelly
|
|
|
|
7 |
p. 747-754
|
artikel
|
| 28 |
Comment on: "Drug–Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"
|
Noguchi, Yoshihiro
|
|
|
|
7 |
p. 809-811
|
artikel
|
| 29 |
Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus
|
Hammerman, Cathy
|
|
|
|
7 |
p. 537-551
|
artikel
|
| 30 |
Comparison of Longitudinal and Cross-Sectional Approaches in Studies About Knowledge, Attitude, and Practices Related to Antibiotic Misuse
|
Mallah, Narmeen
|
|
|
|
7 |
p. 797-809
|
artikel
|
| 31 |
Correction to: Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists
|
Christensen, Rasmus M.
|
|
2019
|
|
7 |
p. 919
|
artikel
|
| 32 |
Corticosteroid-Associated Tendinopathies
|
Blanco, Irene
|
|
2005
|
|
7 |
p. 633-643
|
artikel
|
| 33 |
Data Mining for Prospective Early Detection of Safety Signals in the Vaccine Adverse Event Reporting System (VAERS): A Case Study of Febrile Seizures after a 2010–2011 Seasonal Influenza Virus Vaccine
|
Martin, David
|
|
2013
|
|
7 |
p. 547-556
|
artikel
|
| 34 |
Data Mining for Prospective Early Detection of Safety Signals in the Vaccine Adverse Event Reporting System (VAERS): A Case Study of Febrile Seizures after a 2010–2011 Seasonal Influenza Virus Vaccine
|
Martin, David
|
|
|
|
7 |
p. 547-556
|
artikel
|
| 35 |
Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea
|
Choe, Seon
|
|
|
|
7 |
p. 647-660
|
artikel
|
| 36 |
DNA Barcoding and Pharmacovigilance of Herbal Medicines
|
Boer, Hugo J. de
|
|
2015
|
|
7 |
p. 611-620
|
artikel
|
| 37 |
DNA Barcoding and Pharmacovigilance of Herbal Medicines
|
de Boer, Hugo J.
|
|
|
|
7 |
p. 611-620
|
artikel
|
| 38 |
Does Ibuprofen Worsen COVID-19?
|
Moore, Nicholas
|
|
|
|
7 |
p. 611-614
|
artikel
|
| 39 |
Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters
|
Larivée, Natasha
|
|
2017
|
|
7 |
p. 583-596
|
artikel
|
| 40 |
Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same
|
Olry, Alexandre
|
|
|
|
7 |
p. 615-617
|
artikel
|
| 41 |
Drug-Induced Mitochondrial Toxicity
|
Hargreaves, Iain P.
|
|
2016
|
|
7 |
p. 661-674
|
artikel
|
| 42 |
Drug-Induced Photosensitivity—An Update: Culprit Drugs, Prevention and Management
|
Blakely, Kim M.
|
|
2019
|
|
7 |
p. 827-847
|
artikel
|
| 43 |
Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation
|
Malik, Marek
|
|
2016
|
|
7 |
p. 647-659
|
artikel
|
| 44 |
Drug Interactions of Clinical Importance with Antihyperglycaemic Agents
|
Scheen, André J.
|
|
2005
|
|
7 |
p. 601-631
|
artikel
|
| 45 |
Drug Prescribing Before and During Pregnancy in South West France
|
Crespin, Sophie
|
|
2011
|
|
7 |
p. 595-604
|
artikel
|
| 46 |
Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
|
de Vries, Esther
|
|
|
|
7 |
p. 677-690
|
artikel
|
| 47 |
Drug Treatment for Tuberculosis during Pregnancy
|
Bothamley, Graham
|
|
|
|
7 |
p. 553-565
|
artikel
|
| 48 |
Electronic Drug Interaction Alerts in Ambulatory Care
|
Weingart, Saul N.
|
|
2011
|
|
7 |
p. 587-593
|
artikel
|
| 49 |
Electronic Health Data for Postmarket Surveillance: A Vision Not Realized
|
Moore, Thomas J.
|
|
2015
|
|
7 |
p. 601-610
|
artikel
|
| 50 |
Emerging Skin Toxicities in Patients with Breast Cancer Treated with New Cyclin-Dependent Kinase 4/6 Inhibitors: A Systematic Review
|
Silvestri, Martina
|
|
|
|
7 |
p. 725-732
|
artikel
|
| 51 |
Epidemiological Context of Signalling
|
Stang, Paul
|
|
2007
|
|
7 |
p. 611-613
|
artikel
|
| 52 |
Erratum to: Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database
|
Boonmuang, Pornwalai
|
|
2013
|
|
7 |
p. 583-584
|
artikel
|
| 53 |
Erratum to: Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter
|
Freifeld, Clark C.
|
|
2014
|
|
7 |
p. 555
|
artikel
|
| 54 |
Ethnic Differences in the Risks of Adverse Reactions to Drugs Used in the Treatment of Psychoses and Depression
|
Ormerod, Sara
|
|
2008
|
|
7 |
p. 597-607
|
artikel
|
| 55 |
EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection
|
Postigo, Rodrigo
|
|
2018
|
|
7 |
p. 665-675
|
artikel
|
| 56 |
Evidence of Clinically Meaningful Drug–Drug Interaction With Concomitant Use of Colchicine and Clarithromycin
|
Villa Zapata, Lorenzo
|
|
|
|
7 |
p. 661-668
|
artikel
|
| 57 |
Examination of Baseline Risk Factors for QTc Interval Prolongation in Patients Prescribed Intravenous Haloperidol
|
Muzyk, Andrew J.
|
|
2012
|
|
7 |
p. 547-553
|
artikel
|
| 58 |
Expert Consensus on the Nephrotoxic Potential of 195 Medications in the Non-intensive Care Setting: A Modified Delphi Method
|
Stottlemyer, Britney A.
|
|
|
|
7 |
p. 677-687
|
artikel
|
| 59 |
Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study
|
Minnema, Lotte A.
|
|
2019
|
|
7 |
p. 887-895
|
artikel
|
| 60 |
Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update
|
García-Abeijon, Patricia
|
|
|
|
7 |
p. 625-636
|
artikel
|
| 61 |
From the Uppsala Monitoring Centre
|
Hugman, Bruce
|
|
2005
|
|
7 |
p. 645-646
|
artikel
|
| 62 |
Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims Data
|
Reinau, Daphne
|
|
2018
|
|
7 |
p. 725-730
|
artikel
|
| 63 |
Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
|
Shah, Rashmi R.
|
|
2013
|
|
7 |
p. 491-503
|
artikel
|
| 64 |
Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study
|
Voss, Erica A.
|
|
|
|
7 |
p. 791-807
|
artikel
|
| 65 |
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study
|
Abtahi, Shahab
|
|
|
|
7 |
p. 689-702
|
artikel
|
| 66 |
Impact of Regulatory Guidances and Drug Regulation on Risk Minimization Interventions in Drug Safety
|
Nkeng, Lenhangmbong
|
|
2012
|
|
7 |
p. 535-546
|
artikel
|
| 67 |
Impact of Safety-Related Regulations on Codeine Use in Children: A Quasi-Experimental Study Using Taiwan’s National Health Insurance Research Database
|
Lin, Chih-Wan
|
|
2017
|
|
7 |
p. 615-627
|
artikel
|
| 68 |
Implementing Ecopharmacovigilance in Practice: Challenges and Potential Opportunities
|
Holm, Gisela
|
|
2013
|
|
7 |
p. 533-546
|
artikel
|
| 69 |
Improving the Tolerability of Anticholinergic Agents in the Treatment of Overactive Bladder
|
Dmochowski, Roger
|
|
2005
|
|
7 |
p. 583-600
|
artikel
|
| 70 |
Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study
|
Beau-Lejdstrom, Raphaelle
|
|
|
|
7 |
p. 781-790
|
artikel
|
| 71 |
Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced Nephrotoxicity
|
Wei, Xiao
|
|
|
|
7 |
p. 703-712
|
artikel
|
| 72 |
Inflammation, Monoclonal Antibodies and Depression: Joining the Dots
|
Hunt, David
|
|
2019
|
|
7 |
p. 811-812
|
artikel
|
| 73 |
Influence of Regulatory Measures on the Rate of Spontaneous Adverse Drug Reaction Reporting in Italy
|
Motola, Domenico
|
|
2008
|
|
7 |
p. 609-616
|
artikel
|
| 74 |
Innovations for the Future of Pharmacovigilance
|
Almenoff, June S.
|
|
2007
|
|
7 |
p. 631-633
|
artikel
|
| 75 |
Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
|
de Vries, Sieta T.
|
|
2018
|
|
7 |
p. 697-712
|
artikel
|
| 76 |
Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring
|
Simoons, Mirjam
|
|
2018
|
|
7 |
p. 655-664
|
artikel
|
| 77 |
Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors
|
Sarntivijai, Sirarat
|
|
2016
|
|
7 |
p. 697-707
|
artikel
|
| 78 |
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
|
Ding, Xiao
|
|
|
|
7 |
p. 869-880
|
artikel
|
| 79 |
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
|
Ding, Xiao
|
|
2019
|
|
7 |
p. 869-880
|
artikel
|
| 80 |
Management of Paracetamol Overdose
|
Kozer, Eran
|
|
|
|
7 |
p. 503-512
|
artikel
|
| 81 |
Memantine for the Treatment of Alzheimer’s Disease
|
Farlow, Martin R.
|
|
2008
|
|
7 |
p. 577-585
|
artikel
|
| 82 |
Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy
|
Mula, Marco
|
|
2007
|
|
7 |
p. 555-567
|
artikel
|
| 83 |
Neurocognitive Adverse Effects of Anesthesia in Adults and Children: Gaps in Knowledge
|
Ward, Christopher G.
|
|
2016
|
|
7 |
p. 613-626
|
artikel
|
| 84 |
Neurocognitive Adverse Effects of Anesthesia in Adults and Children: Gaps in Knowledge
|
Ward, Christopher G.
|
|
|
|
7 |
p. 613-626
|
artikel
|
| 85 |
Neuropsychiatric Events with Varenicline: a Modified Prescription-Event Monitoring Study in General Practice in England
|
Buggy, Yvonne
|
|
2013
|
|
7 |
p. 521-531
|
artikel
|
| 86 |
Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole
|
Estborn, Lennart
|
|
2008
|
|
7 |
p. 627-636
|
artikel
|
| 87 |
Patient Reporting in the EU: Analysis of EudraVigilance Data
|
Banovac, Marin
|
|
2017
|
|
7 |
p. 629-645
|
artikel
|
| 88 |
Patient Reporting in the EU: Analysis of EudraVigilance Data
|
Banovac, Marin
|
|
|
|
7 |
p. 629-645
|
artikel
|
| 89 |
Performance of the Standardised MedDRA® Queries for Case Retrieval in the French Spontaneous Reporting Database
|
Géniaux, Hélène
|
|
2014
|
|
7 |
p. 537-542
|
artikel
|
| 90 |
Perioperative Safety of Aprotinin in Coronary Artery Bypass Graft Surgery
|
Augoustides, John G.
|
|
2008
|
|
7 |
p. 557-560
|
artikel
|
| 91 |
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study
|
Daud, Aizati N. A.
|
|
2015
|
|
7 |
p. 651-659
|
artikel
|
| 92 |
Pharmacists in Pharmacovigilance: Can Increased Diagnostic Opportunity in Community Settings Translate to Better Vigilance?
|
Rutter, Paul
|
|
2014
|
|
7 |
p. 465-469
|
artikel
|
| 93 |
Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease
|
Schlatter, Chantal
|
|
2009
|
|
7 |
p. 561-578
|
artikel
|
| 94 |
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment
|
Smolders, Elise J.
|
|
2016
|
|
7 |
p. 589-611
|
artikel
|
| 95 |
Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries
|
Alshammari, Thamir M.
|
|
2019
|
|
7 |
p. 849-868
|
artikel
|
| 96 |
Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries
|
Alshammari, Thamir M.
|
|
|
|
7 |
p. 849-868
|
artikel
|
| 97 |
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety
|
Giovannoni, Gavin
|
|
|
|
7 |
p. 635-643
|
artikel
|
| 98 |
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment – a population-based cohort study in four Nordic countries
|
Dudukina, Elena
|
|
|
|
7 |
p. 661-675
|
artikel
|
| 99 |
Prescription-Event Monitoring
|
Ferreira, Germano
|
|
2007
|
|
7 |
p. 639-641
|
artikel
|
| 100 |
Prevalence of Use of Traditional, Complementary and Alternative Medicine by the General Population: A Systematic Review of National Studies Published from 2010 to 2019
|
Lee, E Lyn
|
|
|
|
7 |
p. 713-735
|
artikel
|
| 101 |
Preventability of Voluntarily Reported or Trigger Tool-Identified Medication Errors in a Pediatric Institution by Information Technology: A Retrospective Cohort Study
|
Stultz, Jeremy S.
|
|
2015
|
|
7 |
p. 661-670
|
artikel
|
| 102 |
Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study
|
Akbarov, Artur
|
|
2015
|
|
7 |
p. 671-682
|
artikel
|
| 103 |
Principles of Data Mining
|
Hand, David J.
|
|
2007
|
|
7 |
p. 621-622
|
artikel
|
| 104 |
Probabilistic Record Linkage for Monitoring the Safety of Artemisinin-Based Combination Therapy in the First Trimester of Pregnancy in Senegal
|
Dellicour, Stephanie
|
|
2013
|
|
7 |
p. 505-513
|
artikel
|
| 105 |
Quantitative Prediction of Adverse Event Probability Due to Pharmacokinetic Interactions
|
Tod, Michel
|
|
|
|
7 |
p. 755-764
|
artikel
|
| 106 |
Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014–2018
|
Barenie, Rachel E.
|
|
|
|
7 |
p. 669-675
|
artikel
|
| 107 |
Readability Assessment of Package Inserts of Biological Medicinal Products from the European Medicines Agency Website
|
Piñero-López, Mª. Ángeles
|
|
2014
|
|
7 |
p. 543-554
|
artikel
|
| 108 |
Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment
|
Davies, Miranda
|
|
|
|
7 |
p. 645-656
|
artikel
|
| 109 |
Renal Adverse Effects of Interferon-α
|
Jankovic, Slobodan
|
|
2005
|
|
7 |
p. 647
|
artikel
|
| 110 |
Reporting of Deaths During Pre-Approval Clinical Trials for Advanced HIV-Infected Populations
|
Johann-Liang, Rosemary
|
|
2005
|
|
7 |
p. 559-564
|
artikel
|
| 111 |
Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of Underreporting
|
Trenque, Thierry
|
|
2013
|
|
7 |
p. 515-519
|
artikel
|
| 112 |
Risk Management of Simvastatin or Atorvastatin Interactions with CYP3A4 Inhibitors
|
Molden, Espen
|
|
2008
|
|
7 |
p. 587-596
|
artikel
|
| 113 |
Risk Minimization of Antibody–Drug Conjugates in Oncology: A Review
|
Lievano, Fabio A.
|
|
|
|
7 |
p. 733-742
|
artikel
|
| 114 |
Risk of Diabetic Ketoacidosis after Exposure to Risperidone or Olanzapine
|
Ramaswamy, Krishnan
|
|
2007
|
|
7 |
p. 589-599
|
artikel
|
| 115 |
Risk of Hospitalization for Hip Fracture and Pneumonia Associated with Antipsychotic Prescribing in the Elderly
|
Pratt, Nicole
|
|
2011
|
|
7 |
p. 567-575
|
artikel
|
| 116 |
Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database
|
Araujo, Mélanie
|
|
|
|
7 |
p. 787-796
|
artikel
|
| 117 |
Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin
|
Eworuke, Efe
|
|
|
|
7 |
p. 753-763
|
artikel
|
| 118 |
Risk Perception and Reasons for Noncompliance in Pharmacovigilance
|
Nichols, Vincent
|
|
2009
|
|
7 |
p. 579-590
|
artikel
|
| 119 |
Safety and Effectiveness of Rasagiline in Chinese Patients with Parkinson’s Disease: A Prospective, Multicenter, Non-interventional Post-marketing Study
|
Su, Wen
|
|
|
|
7 |
p. 637-646
|
artikel
|
| 120 |
Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy
|
Guerrini, Renzo
|
|
2012
|
|
7 |
p. 519-533
|
artikel
|
| 121 |
Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence
|
Sinclair, Julia M. A.
|
|
2016
|
|
7 |
p. 627-645
|
artikel
|
| 122 |
Safety and Usage of Atypical Antipsychotic Medicines in Children
|
Harrison-Woolrych, Mira
|
|
2007
|
|
7 |
p. 569-579
|
artikel
|
| 123 |
Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study
|
de Vries, Sieta T.
|
|
2018
|
|
7 |
p. 713-724
|
artikel
|
| 124 |
Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study
|
de Vries, Sieta T.
|
|
|
|
7 |
p. 713-724
|
artikel
|
| 125 |
Safety of Low-Dose Aprotinin in Coronary Artery Bypass Graft Surgery
|
Kluth, Mario
|
|
2008
|
|
7 |
p. 617-626
|
artikel
|
| 126 |
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials
|
López-Fauqued, Marta
|
|
|
|
7 |
p. 811-823
|
artikel
|
| 127 |
Safety-Related Drug Withdrawals in China Between 1999 and 2021: A Systematic Investigation and Analysis
|
Li, Yanrong
|
|
|
|
7 |
p. 737-745
|
artikel
|
| 128 |
Safety Signal Detection: The Relevance of Literature Review
|
Pontes, Helena
|
|
2014
|
|
7 |
p. 471-479
|
artikel
|
| 129 |
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake Inhibitors
|
Ekhart, Corine
|
|
2018
|
|
7 |
p. 677-683
|
artikel
|
| 130 |
Signal Detection
|
Egberts, Toine C. G.
|
|
2007
|
|
7 |
p. 607-609
|
artikel
|
| 131 |
Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference
|
Cavadino, Alana
|
|
|
|
7 |
p. 765-785
|
artikel
|
| 132 |
Signal Detection in the Pharmaceutical Industry
|
Hauben, Manfred
|
|
2007
|
|
7 |
p. 627-630
|
artikel
|
| 133 |
Signaling COVID-19 Vaccine Adverse Events
|
Harpaz, Rave
|
|
|
|
7 |
p. 765-780
|
artikel
|
| 134 |
Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase®
|
Montastruc, François
|
|
2016
|
|
7 |
p. 689-696
|
artikel
|
| 135 |
Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation
|
Nguyen, Lee S.
|
|
2019
|
|
7 |
p. 813-825
|
artikel
|
| 136 |
Sources of Information on Lymphoma Associated with Anti-Tumour Necrosis Factor Agents
|
Théophile, Héle`ne
|
|
2011
|
|
7 |
p. 577-585
|
artikel
|
| 137 |
Standardised MedDRA Queries
|
Mozzicato, Patricia
|
|
2007
|
|
7 |
p. 617-619
|
artikel
|
| 138 |
Summarising the Evidence for Drug Safety: A Methodological Discussion of Different Meta-Analysis Approaches
|
Prada-Ramallal, Guillermo
|
|
2017
|
|
7 |
p. 547-558
|
artikel
|
| 139 |
Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol
|
Woosley, R. David
|
|
2019
|
|
7 |
p. 907-913
|
artikel
|
| 140 |
Sustained Decline of Direct General Practitioner Reporting of Adverse Drug Reactions in Australia and Paucity in Details of Australian Reports in Safety Advisories
|
Boyd, Ian W.
|
|
|
|
7 |
p. 703-710
|
artikel
|
| 141 |
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations
|
Bagnasco, Diego
|
|
2017
|
|
7 |
p. 559-570
|
artikel
|
| 142 |
The Author’s Reply
|
Gentile, Salvatore
|
|
2007
|
|
7 |
p. 643
|
artikel
|
| 143 |
The Impact of Direct Healthcare Professional Communication on Prescribing Practice in the UK Hospital Setting: An Interrupted Time Series Analysis
|
Thomas, Sarah K.
|
|
2013
|
|
7 |
p. 557-564
|
artikel
|
| 144 |
The International Society of Pharmacovigilance (ISoP) Special Interest Group on Herbal and Traditional Medicines: Towards Progress in Pharmacovigilance for Herbal and Traditional Medicines and Other “Natural Health” Products
|
Barnes, Joanne
|
|
|
|
7 |
p. 619-622
|
artikel
|
| 145 |
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance
|
Bahri, Priya
|
|
2015
|
|
7 |
p. 621-627
|
artikel
|
| 146 |
The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed
|
Younus, Manal M.
|
|
|
|
7 |
p. 619-623
|
artikel
|
| 147 |
The Outcomes of Pregnancy in Women Exposed to the New Macrolides in the First Trimester
|
Bar-Oz, Benjamin
|
|
2012
|
|
7 |
p. 589-598
|
artikel
|
| 148 |
The Pharmacovigilance System in India
|
Kshirsagar, Nilima
|
|
2005
|
|
7 |
p. 647-650
|
artikel
|
| 149 |
The Power of the Case Narrative - Can it be Brought to Bear on Duplicate Detection?
|
Norén, G. Niklas
|
|
2017
|
|
7 |
p. 543-546
|
artikel
|
| 150 |
The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis
|
Rolfes, Leàn
|
|
2017
|
|
7 |
p. 607-614
|
artikel
|
| 151 |
The Risk of Ischaemic Colitis in Irritable Bowel Syndrome Patients Treated with Serotonergic Therapies
|
Lewis, James H.
|
|
2011
|
|
7 |
p. 545-565
|
artikel
|
| 152 |
The Safety of H1N1 Vaccine in Children in Saudi Arabia
|
Aljadhey, Hisham
|
|
2012
|
|
7 |
p. 555-561
|
artikel
|
| 153 |
The Safety of Metoclopramide in Children: A Systematic Review and Meta-Analysis
|
Lau Moon Lin, Melissa
|
|
2016
|
|
7 |
p. 675-687
|
artikel
|
| 154 |
Thoughts on Signal Detection in Pharmacovigilance
|
Shakir, Saad A.W.
|
|
2007
|
|
7 |
p. 603-606
|
artikel
|
| 155 |
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
|
Scott, Ian C.
|
|
2018
|
|
7 |
p. 645-653
|
artikel
|
| 156 |
Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy
|
Nordeng, Hedvig
|
|
2005
|
|
7 |
p. 565-581
|
artikel
|
| 157 |
Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
|
de Vries, Sieta T.
|
|
2019
|
|
7 |
p. 881-886
|
artikel
|
| 158 |
Use of Contemporary Antidepressants during Breastfeeding
|
Einarson, Adrienne
|
|
2007
|
|
7 |
p. 643
|
artikel
|
| 159 |
Use of FDA’s Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure
|
Eworuke, Efe
|
|
2019
|
|
7 |
p. 897-906
|
artikel
|
| 160 |
Use of Triage Strategies in the WHO Signal-Detection Process
|
Lindquist, Marie
|
|
2007
|
|
7 |
p. 635-637
|
artikel
|
| 161 |
Using Probabilistic Record Linkage of Structured and Unstructured Data to Identify Duplicate Cases in Spontaneous Adverse Event Reporting Systems
|
Kreimeyer, Kory
|
|
2017
|
|
7 |
p. 571-582
|
artikel
|
| 162 |
Using the Symmetry Analysis Design to Screen for Adverse Effects of Non-vitamin K Antagonist Oral Anticoagulants
|
Hellfritzsch, Maja
|
|
2018
|
|
7 |
p. 685-695
|
artikel
|
| 163 |
You’ve Found a Safety Signal —Now What?
|
Kahn, Sidney N.
|
|
2007
|
|
7 |
p. 615-616
|
artikel
|
Tijdschrift beschrijving